Dihydrotestosterone (DHT) LC/MS Blood Test

While Testosterone receives all the mainstream attention, Dihydrotestosterone (DHT) is the true, apex androgen driving the most visible and consequential signs of aging in men and hyperandrogenism in women.

As a senior clinical endocrinologist, I constantly remind my patients that Testosterone is largely a prohormone. In specific target tissues—namely your hair follicles, prostate gland, and skin—testosterone is converted by the enzyme 5-alpha-reductase (5AR) into DHT. DHT binds to androgen receptors with 3 to 5 times the affinity of testosterone and dissociates five times slower. It is the absolute primary biological driver behind male pattern baldness (androgenetic alopecia) and Benign Prostatic Hyperplasia (BPH). In women, elevated DHT is a leading cause of severe, treatment-resistant hirsutism and PCOS-related hair thinning. Testing DHT using high-precision Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is the only reliable way to map this highly localized enzymatic conversion.

Advanced Clinical Diagnostic Utility of DHT Testing

To accurately interpret your androgenic profile, one must understand that DHT operates as an intracrine and paracrine hormone—meaning it does its most profound work locally within the tissue. Serum DHT gives us the systemic systemic footprint of this localized activity.

1. The 5-Alpha-Reductase Pathway

• The Amplification Enzyme: About 10% of your circulating testosterone is irreversibly reduced to DHT by the 5AR enzyme. If you have an aggressive genetic expression of 5AR (particularly Type II in the prostate and hair follicles), even 'normal' testosterone levels will result in massive DHT production, rapidly miniaturizing your hair follicles and causing prostatic cellular proliferation. This test quantifies exactly how aggressive your 5AR pathway is.

2. The LC-MS/MS Supremacy

• Bypassing Immunoassay Failure: Never allow a clinic to measure your DHT using a standard immunoassay. DHT circulates in the blood at concentrations approximately 1/10th that of testosterone, and its molecular structure is nearly identical to other androgens. Standard immunoassays suffer from massive cross-reactivity, frequently mistaking testosterone or DHEA for DHT and yielding falsely high results. Liquid Chromatography-Mass Spectrometry (LC-MS/MS) physically separates the molecules by mass and electrical charge, guaranteeing 100% analytical specificity. It is the undisputed gold standard.

3. Female Hyperandrogenism & Intracrine Metabolism

• The Hidden PCOS Driver: In women, the ovaries and adrenal glands produce precursors (like androstenedione) that convert to DHT directly in the skin and hair follicles. A female patient may have 'normal' Total Testosterone, but if her peripheral 5AR activity is upregulated, her DHT will skyrocket, driving severe acne and male-pattern hair loss on the scalp. LC-MS/MS DHT testing is vital for phenotyping these complex hyperandrogenic states.

You should prioritize this advanced endocrine evaluation when:

• You are a male experiencing rapid vertex (crown) or temporal (hairline) hair recession and are considering initiating a 5AR inhibitor (Finasteride) to establish a physiological baseline.
• You are currently taking Finasteride or Dutasteride and need to verify if the dosage is actively suppressing your systemic DHT to therapeutic targets (often < 150 pg/mL for effective hair retention).
• You are experiencing symptoms of an enlarged prostate (frequent nighttime urination, weak stream) and need to evaluate the hormonal driver.
• You are a female experiencing unexplained, male-pattern facial hair growth (hirsutism) or severe scalp hair thinning that has not been explained by standard thyroid or testosterone testing.

This test is an absolute necessity for dermatologists managing aggressive androgenetic alopecia, urologists titrating BPH medications, endocrinologists investigating Post-Finasteride Syndrome (PFS), and patients on Testosterone Replacement Therapy (TRT) who want to monitor their prostate risk profile.

• Androgenetic Alopecia (Male and Female Pattern Baldness)
• Benign Prostatic Hyperplasia (BPH)
• 5-Alpha-Reductase Enzyme Overactivity or Deficiency
• Hyperandrogenism / Idiopathic Hirsutism (in Women)